Immunoconjugate with Docetaxel

· Seagen Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Immunoconjugate with Docetaxel, covering 2011-10-24 to 2011-10-24. Get the full timeline:

Most recent: Clinical Trial Update: Safety/Efficacy Study of Immunoconjugate With Docetaxel in Non-small Cell Lung Carcinoma [Phase 2]